# Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients

> **NCT03606616** · — · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 142 (actual)

## Conditions studied

- Breast Cancer
- Sentinel Lymph Node
- Local Recurrence of Malignant Tumor of Breast

## Interventions

- **PROCEDURE:** no further ALND arm

## Key facts

- **NCT ID:** NCT03606616
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-01
- **Primary completion:** 2019-11-30
- **Final completion:** 2019-11-30
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2022-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03606616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03606616, "Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03606616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*